- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 15.84M sh |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $2.83M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $21.48M |
| Current Liabilities | Q1 2025 · Dec 29, 2024 | $25.4M |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $22.76M |
| Total Liabilities | Q1 2025 · Dec 29, 2024 | $27.05M |
| Current Assets | Q1 2025 · Mar 30, 2025 | $25.34M |
| Current Assets | Q1 2025 · Dec 29, 2024 | $29.6M |
| Total Assets | Q1 2025 · Mar 30, 2025 | $49.08M |
| Total Assets | Q1 2025 · Dec 29, 2024 | $51.93M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 14.55M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $85K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $147K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $22.25M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $16.9M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.35M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $1.32M |
| Net Income | Q1 2025 · Mar 31, 2024 | $108K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $132K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $3.8M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.87M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $5.67M |